Search results
1 company and 4 research reports found for "alchemia"
Company results
- Alchemia
Alchemia is an ASX-listed drug development company with a late stage oncology pipeline and generic f...
Sector reports
No sector reports have been found.
Research results
-
Alchemia
A pivotal period
QuickView | Pharmaceutical & healthcare | 03/10/2014Phase III study results due in October with Alchemia’s HA-Irinotecan in metastatic colorectal cancer represent a defining moment in the company&...
-
Alchemia
Pivotal Phase III result due in Q214
QuickView | Pharmaceutical & healthcare | 25/02/2014Alchemia is approaching the defining moment in its history, with the top-line data from the pivotal Phase III study of HA-Irinotecan in metastatic col...
-
Alchemia
Merck CHIMEs in
QuickView | Pharmaceutical & healthcare | 07/06/2013Merck Serono’s collaboration on a Phase II trial of HA-Irinotecan in combination with Erbitux (cetuximab) bodes well for validation of Alchemia&...
-
Alchemia
A HyACT to follow
QuickView | Pharmaceutical & healthcare | 25/03/2013Alchemia’s c 60% share price decline after the failed spin-out of its oncology division, Audeo, belies a promising late stage cancer candidate i...